Newborn screening for cystic fibrosis

Pediatric Annals

Volumn 32, Issue 8, 2003, Pages 528-535

  Parad, Richard B ^a   Comeau, Anne Marie ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CWN 418 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; FLUCLOXACILLIN; PSEUDOMONAS VACCINE;

CHILD CARE; CYSTIC FIBROSIS; GENETIC COUNSELING; HUMAN; LUNG INJURY; MALNUTRITION; NEWBORN SCREENING; REVIEW; UNITED STATES;

EID: 0042029359     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20030801-10     Document Type: Review

References (45)

1. The Cystic Fibrosis Mutations Database. http://www.genet.sickkids.on.ca/cftr. Accessed July 14, 2003.
2. Farrell PM, Kosorok MR, Rock MJ, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics. 2001;107:1-13.
3. Wang SS, O'Leary LA, FitzSimmons SC, Khoury MJ. The impact of early cystic fibrosis diagnosis on pulmonary function in children. J Pediatr. 2002;141:804-810.
4. Cono J, Qualls N, Khoury M, Hannon W. Newborn Screening for Cystic Fibrosis: A Paradigm for Public Health Genetics Policy Development. Proceedings of a 1997 Workshop. MMWR. 1997;46[RR-16]:1-24
5. Abman SH, Ogle JW, Butler-Simon N, Rumack CM, Accurso FJ. Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J Pediatr. 1988;113:826-830.
6. Crossley JR, Elliott RB, Smith PA. Dried-blood spot screening for cystic fibrosis in the newborn. Lancet. 1979;1(8114):472-474.
7. Iovanna JL, Ferec C, Sarles J, Dagorn JC. The pancreatitis-associated protein (PAP). A new candidate for neonatal screening of cystic fibrosis. C R Acad Sci III. 1994;317:561-564.
8. Gregg RG, Simantel A, Farrell PM, et al. Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods. Pediatrics. 1997;99:819-824.
9. Farrell PM, Kosorok MR, Laxova A, et al. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. N Engl J Med. 1997;337:963-969.
10. Gregg RG, Wilfond BS, Farrell PM, et al. Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols. Am J Hum Genet. 1993;52:616-626.
11. Massie RJ, Olsen M, Glazner J, Robertson CF, Francis I. Newborn screening for cystic fibrosis in Victoria: 10 years' experience (1989-1998). Med J Aust. 2000;172:584-587.
12. Grody WW, Cutting GR, Klinger KW, et al. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med. 2001;3:149-154.
13. Scotet V, De Braekeleer M, Audrezet MP, et al. Prevalence of CFTR mutations in hypertrypsinaemia detected through neonatal screening for cystic fibrosis. Clin Genet. 2001;59:42-47.
14. Padoan R, Bassotti A, Seia M, Corbetta C. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations. Eur J Pediatr. 2002;161:212-215.
15. Castellani C, Tamanini A, Mastella G. Protracted neonatal hypertrypsinogenaemia, normal sweat chloride, and cystic fibrosis. Arch Dis Child. 2000;82:481-482.
16. Massie J, Du SD, Forshaw K, Carlin J, Forrest SM. The relationship between neonatal immunoreactive trypsinogen, AF508, and IVS8-5T [letter]. J Med Genet. 2000;37:629-632.
17. Castellani C, Bonizzato A, Mastella G. CFTR mutations and IVS8-5T variant in newborns with hypertrypsinaemia and normal sweat test. J Med Genet. 1997;34:297-301.
18. West SE, Zeng L, Lee BL, et al. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. JAMA. 2002;287:2958-2967.
19. Kosorok MR, Jalaluddin M, Farrell PM, et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol. 1998;26:81-88.
20. Kosorok MR, Zeng L, West SE, et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol. 2001;32:277-287.
21. Nixon GM, Armstrong DS, Carzino R, et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr. 2001;138:699-704.
22. Waters DL, Wilcken B, Irwing L, et al. Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed. 1999;80:F1-F7.
23. Chatfield S, Owen G, Ryley HC, et al. Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after 5 years of screening. Arch Dis Child. 1991;66:29-33.
24. Bowling F, Cleghorn G, Chester A, et al. Neonatal screening for cystic fibrosis. Arch Dis Child. 1988;63:196-198.
25. Assael BM, Castellani C, Ocampo MB, et al. Epidemiology and survival analysis of cystic fibrosis in an area of intense neonatal screening over 30 years. Am J Epidemiol. 2002;156:397-401.
26. Dankert-Roelse JE, te Meerman GJ, Martijn A, Ten Kate LP, Knol K. Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screening. J Pediatr. 1989;114:362-367.
27. Dankert-Roelse JE, te Meerman GJ. Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre [see comments]. Thorax. 1995;50:712-718.
28. Merelle ME, Schouten JP, Gerritsen J, Dankert-Roelse JE. Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients. Eur Respir J. 2001;18:306-315.
29. Siret D, Bretaudeau G, Branger B, et al. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: A 10-year retrospective study in a French region (Brittany). Pediatr Pulmonol. 2003;35(5):342-349.
30. Scotet V, De Braekeleer M, Roussey M, et al. Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis. Lancet. 2000;356(9232):789-794.
31. Weaver LT, Green MR, Nicholson K, Mills J, Heeley ME, Kuzemko JA et al. Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period. Arch Dis Child. 1994;70:84-89.
32. Sokol RJ, Reardon MC, Accurso FJ, et al. Fatsoluble vitamins in infants identified by cystic fibrosis newborn screening. Pediatr Pulmonol Suppl. 1991;7:52-55.
33. Feranchak AP, Sontag MK, Wagener JS, et al. Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. J Pediatr. 1999;135(5):601-610.
34. Bronstein MN, Sokol RJ, Abman SH, et al. Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis. J Pediatr 1992;120:533-540.
35. Abman SH, Ogle JW, Harbeck RJ, et al. Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening. J Pediatr. 1991;119:211-217.
36. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DWH. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 1995;151:1075-1082.
37. Mohon RT, Wagener JS, Abman SH, Seltzer WK, Accurso FJ. Relationship of genotype to early pulmonary function in infants with cystic fibrosis identified through neonatal screening. J Pediatr. 1993;122:550-555.
38. Farrell PM, Koscik RE. Sweat chloride concentrations in infants homozygous or heterozygous for ΔF508 cystic fibrosis. Pediatrics. 1996;97:524-528.
39. US Task Force on Newborn Screening. Report of US Task Force on Newborn Screening. Pediatrics. 2000;106:389-422.
40. Al-Jader LN, Goodchild MC, Ryley HC, Harper PS. Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis. Adv Exp Med Biol. 1991;290:347-348.
41. Tluczek A, Mischler EH, Farrell PM, et al. Parents' knowledge of neonatal screening and response to false-positive cystic fibrosis testing. J Dev Behav Pediatr. 1992;13:181-186.
42. Mischler EH, Wilfond BS, Fost N, et al. Cystic Fibrosis Newborn Screening; Impact on Reproductive Behavior and Implicatations for Genetic Counseling. Pediatrics. 1998;102:44-51.
43. Helton JL, Harmon RJ, Robinson N, Accurso FJ. Parental attitudes toward newborn screening for cystic fibrosis. Pediatr Pulmonol Suppl. 1991;7:23-28.
44. Al-Jader LN, Goodchild MC, Ryley HC, Harper PS. Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis. Clin Genet. 1990;38:460-465.
45. Boland C, Thompson NL. Effects of newborn screening of cystic fibrosis on reported maternal behaviour. Arch Dis Child. 1990;65:1240-1244.